Nexalin Technology (NXL) Other Accumulated Expenses (2021)

Nexalin Technology (NXL) recorded quarterly Other Accumulated Expenses of $42843.0 in Q4 2021.

Nexalin Technology (NXL) Other Accumulated Expenses (2021) Analysis & Trends

Nexalin Technology's Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $42843.0 for Q4 2021.

In Q4 2021, Other Accumulated Expenses changed N/A year-over-year to $42843.0; the TTM figure through Dec 2021 stood at $42843.0 (changed N/A YoY), while the FY2021 annual figure was $42843.0, changed N/A from the prior year.
Other Accumulated Expenses was $42843.0 for Q4 2021 at Nexalin Technology.
In the past five years, Other Accumulated Expenses ranged from a high of $42843.0 in Q4 2021 to a low of $42843.0 in Q4 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Nexalin Technology	8.72 Mn	6.01 Mn	13,133.00

Historic Data

Download Data

Date	Value
Dec 31, 2021	42,843.00